TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29757758

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided pulsed radiofrequency (PRF) at 42°C for 120 seconds
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham group (mimicking PRF)
Number of subjects: 0
Study: 28034308

Group type: EXPERIMENTAL
Intervention: Mitomycin-C (MMC)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Collagen Matrix (CM)
Number of subjects: 94
Study: 23909480

Group type: EXPERIMENTAL
Intervention: 450 IU recombinant FSH (cycle 2)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal saline (cycle 1)
Number of subjects: 10
Study: 21910559

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Nonmindfulness stress reduction (NMSR)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Inactive control group (financial incentive)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Inactive control group (nonincentive)
Number of subjects: 48
Study: 20352546

Group type: EXPERIMENTAL
Intervention: Personalized feedback intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard information (control)
Number of subjects: 0
Study: 17913583

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UFH)
Number of subjects: 530

Group type: COMPARATOR
Intervention: No unfractionated heparin (no UFH)
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Overall population (UFH and no UFH)
Number of subjects: 530
Study: 16207788

Group type: EXPERIMENTAL
Intervention: Theta oscillations gated by a working-memory task in occipital/parietal cortex (45/157 sites)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Theta oscillations gated by a working-memory task in temporal cortex (23/280 sites)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Theta oscillations in frontal cortex (2/182 sites)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Coherence measures of nearby gated sites (<20 mm)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Coherence measures of distant gated sites
Number of subjects: 10
Study: 14609161

Group type: EXPERIMENTAL
Intervention: Antibiotic-impregnated shunt (AIS) system
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control shunt system
Number of subjects: 110
Study: 11016157

Group type: EXPERIMENTAL
Intervention: Ascoril cough formula
Number of subjects: 50

Group type: COMPARATOR
Intervention: Other cough formula
Number of subjects: 50
Study: 8845887

Group type: EXPERIMENTAL
Intervention: Hospital replacement mattress
Number of subjects: 23

Group type: COMPARATOR
Intervention: Standard hospital mattress
Number of subjects: 23
Study: 1342258

Group type: EXPERIMENTAL
Intervention: Baseline serum cholesterol levels in women under age 65
Number of subjects: 5455

Group type: EXPERIMENTAL
Intervention: Baseline serum cholesterol levels in older hypertensive women
Number of subjects: 5455

Group type: EXPERIMENTAL
Intervention: Baseline serum cholesterol levels in younger and older hypertensive men
Number of subjects: 5455
Study: 6233548

Group type: EXPERIMENTAL
Intervention: Duovent
Number of subjects: 16

Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 16
Study: 30540568

Group type: EXPERIMENTAL
Intervention: Cabergoline
Number of subjects: 116

Group type: COMPARATOR
Intervention: Nonintervention (Control)
Number of subjects: 116
Study: 29481507

Group type: EXPERIMENTAL
Intervention: Personalized digital guiding plate-assisted radiofrequency
Number of subjects: 93

Group type: COMPARATOR
Intervention: Traditional method
Number of subjects: 93
Study: 27490915

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 25675568

Group type: EXPERIMENTAL
Intervention: Acupuncture therapy at three nasal points (Yingxiang, Yintang, Bitong) and syndrome differentiation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral administration of loratadine, 10 mg daily for 4 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acupuncture therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Loratadine
Number of subjects: 60
Study: 22988126

Group type: EXPERIMENTAL
Intervention: Male applicant
Number of subjects: 127

Group type: COMPARATOR
Intervention: Female applicant
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Preexisting subtle bias against women
Number of subjects: 127
Study: 20522355

Group type: EXPERIMENTAL
Intervention: Fascia iliaca block
Number of subjects: 23

Group type: COMPARATOR
Intervention: Femoral nerve block
Number of subjects: 23
Study: 18628422

Group type: EXPERIMENTAL
Intervention: 12-month moderate-to-vigorous aerobic exercise intervention (6 days/week, 60 minutes/day, 60-85% maximum heart rate)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 202
Study: 16042036

Group type: EXPERIMENTAL
Intervention: Alzheimer's disease and depression (AD + D)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Alzheimer's disease without depression (AD - D)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Normal older adults
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 301
Study: 12503784

Group type: EXPERIMENTAL
Intervention: Wavelet-based fractal analysis method
Number of subjects: 23
Study: 10348228

Group type: EXPERIMENTAL
Intervention: Praziquantel treatment
Number of subjects: 181
Study: 7805930

Group type: EXPERIMENTAL
Intervention: DMSO
Number of subjects: 488

Group type: COMPARATOR
Intervention: 1,2-propanediol
Number of subjects: 488

Group type: COMPARATOR
Intervention: DMSO and 1,2-propanediol
Number of subjects: 488
Study: 1931536

Group type: EXPERIMENTAL
Intervention: Lactulose (15 ml bd, increasing to 60 ml daily if necessary)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Ispaghula (one sachet bd)
Number of subjects: 124
Study: 6804082

Group type: EXPERIMENTAL
Intervention: Methanol extraction residue of Bacillus Calmette-Guerin (MER/BCG)
Number of subjects: 196

Group type: COMPARATOR
Intervention: No immunotherapy (Control)
Number of subjects: 196
Study: 31695344

Group type: EXPERIMENTAL
Intervention: Nordic walking (NW)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Walking (W)
Number of subjects: 38
Study: 29783024

Group type: EXPERIMENTAL
Intervention: Iclaprim 80 mg intravenously every 12 h for 5-14 days
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Vancomycin 15 mg/kg intravenously every 12 h for 5-14 days
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Iclaprim
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 1200
Study: 26817490

Group type: EXPERIMENTAL
Intervention: Carbon-heated tobacco product (CHTP)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Smoking abstinence (SA)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Combustible cigarettes (CCs)
Number of subjects: 112
Study: 25230154

Group type: EXPERIMENTAL
Intervention: 40 mg baclofen
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 22721632

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (IMN) 2 40-mg tablets
Number of subjects: 200

Group type: COMPARATOR
Intervention: Pyridoxine (placebo) 2 40-mg tablets
Number of subjects: 200
Study: 20585761

Group type: EXPERIMENTAL
Intervention: Food and nicotine deprivation (12 h food deprivation, 18 h nicotine deprivation)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nicotine deprivation only (18 h nicotine deprivation)
Number of subjects: 30
Study: 17106061

Group type: EXPERIMENTAL
Intervention: Pioglitazone (45 mg/day)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (8 mg/day)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Pioglitazone + drug-naïve diabetics
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Pioglitazone + sulfonylurea-treated diabetics
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Rosiglitazone + sulfonylurea-withdrawn diabetics
Number of subjects: 64
Study: 15646603

Group type: EXPERIMENTAL
Intervention: Academic detailing program
Number of subjects: 88

Group type: COMPARATOR
Intervention: Practice as usual
Number of subjects: 88
Study: 11306159

Group type: EXPERIMENTAL
Intervention: Titanium restorations
Number of subjects: 110

Group type: COMPARATOR
Intervention: High gold alloy restorations
Number of subjects: 110
Study: 9704685

Group type: EXPERIMENTAL
Intervention: 1994 treatment (aspirin, ACE inhibitors, beta-blockers, nitrates, thrombolytic therapy, coronary angiography, PTCA, CABG)
Number of subjects: 835

Group type: EXPERIMENTAL
Intervention: 1994 cohort
Number of subjects: 835
Study: 8046740

Group type: EXPERIMENTAL
Intervention: Pentamidine therapy
Number of subjects: 56
Study: 3291088

Group type: EXPERIMENTAL
Intervention: Positive Expiratory Pressure (PEP)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Forced Expiration Technique (FET)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control
Number of subjects: 8
Study: 30413312

Group type: EXPERIMENTAL
Intervention: Meat-based complementary diet
Number of subjects: 53

Group type: COMPARATOR
Intervention: Dairy-based complementary diet
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 53
Study: 28838379

Group type: EXPERIMENTAL
Intervention: Olaratumab + Paclitaxel/Carboplatin (P/C)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Paclitaxel/Carboplatin (P/C) alone
Number of subjects: 131
Study: 25113275

Group type: EXPERIMENTAL
Intervention: 0.1Hz rTMS applied at the onset of training movements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 0
Study: 23813295

Group type: EXPERIMENTAL
Intervention: Naltrexone + CBT
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Acamprosate + CBT
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Disulfiram + CBT
Number of subjects: 243

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 243
Study: 22054050

Group type: EXPERIMENTAL
Intervention: Quetiapine (300-800 mg/d)
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Lithium (0.6-1.2 mEq/L)
Number of subjects: 1226

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1226
Study: 19794987

Group type: EXPERIMENTAL
Intervention: Antihistamine (2 mL, 45.5 mg pheniramine maleate)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Normal saline (2 mL)
Number of subjects: 171
Study: 14745084

Group type: EXPERIMENTAL
Intervention: CEP-1347
Number of subjects: 30
Study: 10520808

Group type: EXPERIMENTAL
Intervention: Endurance exercise training (supervised walking three times a week for 16 weeks at 40% to 70% of peak oxygen uptake)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 19
Study: 7737444

Group type: EXPERIMENTAL
Intervention: Medical assistant telephone call
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Physician telephone call
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Overall response for widows
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Overall response for other marital groups
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Cost per intervention for physician telephone call
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Cost per intervention for physician letter
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Cost per intervention for medical assistant call
Number of subjects: 151
Study: 1704245

Group type: EXPERIMENTAL
Intervention: Self-help materials (audiotape and booklet) in addition to current treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (current treatment only)
Number of subjects: 0
Study: 7286031

Group type: EXPERIMENTAL
Intervention: Intravenous injection of diacetolol 100 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral administration of diacetolol 100 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral administration of diacetolol 400 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral administration of diacetolol 800 mg
Number of subjects: 6
Study: 30670036

Group type: COMPARATOR
Intervention: Pedometer-based walking intervention (postal)
Number of subjects: 1023

Group type: COMPARATOR
Intervention: Pedometer-based walking intervention (nurse support)
Number of subjects: 1023
Study: 30206192

Group type: EXPERIMENTAL
Intervention: Eye-health program based on social learning theory (EPST) including eye-health education and eye exercises
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 141
Study: 26773246

Group type: EXPERIMENTAL
Intervention: Carbetocin (100mcg intravenous bolus)
Number of subjects: 547

Group type: COMPARATOR
Intervention: Oxytocin (10IU intravenous bolus)
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Carbetocin
Number of subjects: 547

Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 547
Study: 25157951

Group type: EXPERIMENTAL
Intervention: Extended-release oxycodone/acetaminophen (ER OC/APAP) 15/650 mg total dose, two tablets every 12 hours for ≤ 14 days
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Extended-release oxycodone/acetaminophen (ER OC/APAP)
Number of subjects: 146
Study: 21811833

Group type: EXPERIMENTAL
Intervention: Pazopanib 400 mg crushed tablet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pazopanib 400 mg oral suspension
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole tablet administration
Number of subjects: 0
Study: 19410947

Group type: EXPERIMENTAL
Intervention: AcrySof IQ IOL
Number of subjects: 524

Group type: COMPARATOR
Intervention: AcrySof SN60AT IOL
Number of subjects: 524
Study: 17467954

Group type: EXPERIMENTAL
Intervention: Prolactin-sparing anti-psychotics (e.g., olanzapine) with specific interventions (n=8)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Prolactin-raising anti-psychotics with specific interventions (n=8)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Prolactin-sparing anti-psychotics with no specific interventions (n=5)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Prolactin-raising anti-psychotics with no specific interventions (n=20)
Number of subjects: 38
Study: 15681525

Group type: COMPARATOR
Intervention: bicalutamide (150 mg/d) plus placebo
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: bicalutamide (150 mg/d) plus tamoxifen (20 mg/d)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: bicalutamide (150 mg/d) plus anastrozole (1 mg/d)
Number of subjects: 114
Study: 11888875

Group type: EXPERIMENTAL
Intervention: Peritumoral (PT) injection of blue dye
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Subareolar (SA) injection of blue dye
Number of subjects: 332
Study: 9793614

Group type: EXPERIMENTAL
Intervention: Rectal administration of tramadol suppositories (100 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intravenous injection of tramadol (2 ml solution for injection, 100 mg)
Number of subjects: 10
Study: 7547045

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 50
Study: 2505603

Group type: EXPERIMENTAL
Intervention: Warm-up period before exercise
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Sublingual nitroglycerin (0.5 mg)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise during angiography
Number of subjects: 33
Study: 31533741

Group type: EXPERIMENTAL
Intervention: Community based educational interventions targeting health providers and women in childbearing period
Number of subjects: 20494
Study: 27441916

Group type: EXPERIMENTAL
Intervention: Hypoxia group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normoxia group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 26721131

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with cognitive training (acupuncture at Baihui (GV 20), Fengchi (GB 20), Geshu (BL 17), and Fenglong (ST 40), once a day for 4 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cognitive training and conventional treatment (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with cognitive training
Number of subjects: 60
Study: 24018575

Group type: EXPERIMENTAL
Intervention: LACE training (20 sessions)
Number of subjects: 50

Group type: COMPARATOR
Intervention: LACE training (less than 20 sessions)
Number of subjects: 50
Study: 23376757

Group type: EXPERIMENTAL
Intervention: Educational strategy (poster contest themed, 'Handwashing with Soap') in 23 NICHE primary schools
Number of subjects: 51

Group type: COMPARATOR
Intervention: NICHE intervention (handwashing stations with treated water and soap)
Number of subjects: 51
Study: 19224928

Group type: EXPERIMENTAL
Intervention: Patients with AVDE after PCI
Number of subjects: 883

Group type: COMPARATOR
Intervention: Patients without AVDE after PCI
Number of subjects: 883
Study: 17456656

Group type: EXPERIMENTAL
Intervention: Aprepitant 40 mg
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: Aprepitant 125 mg
Number of subjects: 805

Group type: COMPARATOR
Intervention: Ondansetron 4 mg IV
Number of subjects: 805
Study: 14971818

Group type: EXPERIMENTAL
Intervention: Endoscopic balloon dilatation
Number of subjects: 104

Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy
Number of subjects: 104
Study: 12482109

Group type: EXPERIMENTAL
Intervention: Pulsed estrogen therapy (Aerodiol) at a dose of 300 microg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pulsed estrogen therapy (Aerodiol)
Number of subjects: 0
Study: 9579493

Group type: EXPERIMENTAL
Intervention: 0.7% end‐tidal isoflurane
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 10
Study: 8080944

Group type: EXPERIMENTAL
Intervention: Tobacco use
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Lifelong coffee drinking
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Alcohol consumption (heaviest drinkers)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Saccharin intake
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Infrequent consumption of carrots, spinach, and marrows
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Living in a non-Mediterranean area
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Being born in a Mediterranean area
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: High consumption of spices
Number of subjects: 219
Study: 2676648

Group type: EXPERIMENTAL
Intervention: Salsalate (1.5 g twice daily)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Piroxicam (20 mg after evening meal)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Salsalate and Piroxicam
Number of subjects: 43
Study: 1234807

Group type: EXPERIMENTAL
Intervention: Chemotherapy with Melphalan
Number of subjects: 149

Group type: COMPARATOR
Intervention: Whole abdominal irradiation with additional treatment to the pelvis
Number of subjects: 149

Group type: COMPARATOR
Intervention: Whole abdominal irradiation followed by strip irradiation to the entire abdomen
Number of subjects: 149
Study: 30668137

Group type: EXPERIMENTAL
Intervention: Cognitive Frailty Index (CFI) metrics - mean reaction time (RT) for total, first-half and second-half trials per condition
Number of subjects: 607
Study: 30913134

Group type: EXPERIMENTAL
Intervention: Short-term type 1 diabetes mellitus (T1DM)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study: 28138315

Group type: EXPERIMENTAL
Intervention: 7.5% CHO ingestion (CHOI)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 15% CHO mouth rinse (CHOR)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo mouth rinse (PLAR)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo ingestion (PLAI)
Number of subjects: 9
Study: 26602230

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 23741991

Group type: EXPERIMENTAL
Intervention: Fosamprenavir/ritonavir 1400/100 mg with abacavir/lamivudine 600 mg/300 mg
Number of subjects: 101

Group type: COMPARATOR
Intervention: Efavirenz 600 mg with abacavir/lamivudine 600 mg/300 mg
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 101

Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 101
Study: 21532504

Group type: EXPERIMENTAL
Intervention: TC + endostar
Number of subjects: 126

Group type: COMPARATOR
Intervention: TC + placebo
Number of subjects: 126
Study: 19172543

Group type: EXPERIMENTAL
Intervention: EE 30 microg + DRSP 3 mg
Number of subjects: 55

Group type: COMPARATOR
Intervention: EE 30 microg + CMA 2 mg
Number of subjects: 55
Study: 17927921

Group type: EXPERIMENTAL
Intervention: Monaural in-the-ear (ITE) hearing aid
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Bilateral ITE hearing aids
Number of subjects: 34

Group type: COMPARATOR
Intervention: Unilateral and bilateral hearing aids
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Systematic screening programme
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Audiometric screening instrument
Number of subjects: 34
Study: 15014936

Group type: EXPERIMENTAL
Intervention: Physiotherapist-delivered continence promotion program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 0
Study: 11718974

Group type: EXPERIMENTAL
Intervention: Floor support surface
Number of subjects: 4

Group type: COMPARATOR
Intervention: Overlay inflated support surface
Number of subjects: 4

Group type: COMPARATOR
Intervention: Overlay deflated support surface
Number of subjects: 4

Group type: COMPARATOR
Intervention: Low-air-loss inflated support surface
Number of subjects: 4

Group type: COMPARATOR
Intervention: Foam mattress support surface
Number of subjects: 4
Study: 9426671

Group type: EXPERIMENTAL
Intervention: Internal ultrasonic-assisted tumescent liposuction (I-UATL)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Tumescent liposuction (TL)
Number of subjects: 28
Study: 8387904

Group type: EXPERIMENTAL
Intervention: Single dose of 500 mg MK-886
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Multiple doses of 250 mg MK-886 every 8 hours
Number of subjects: 36
Study: 3434603

Group type: EXPERIMENTAL
Intervention: Groups with humor during hat-making activity
Number of subjects: 28

Group type: COMPARATOR
Intervention: Groups without humor during bookmark-making activity
Number of subjects: 28